TCAs versus placebo - National Center for Biotechnology Information

MULSANT2001B
Mulsant, B. H., Sweet, R. A., Rosen, J., Pollock, B. G., Zubenko, G. S., Flynn, T. et al. (2001). A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus
placebo in the treatment of psychotic depression in late life. Journal of Clinical Psychiatry, 62, 597-604.
MURPHY1978A (Published Data Only)
Murphy, J. E. (1978). Mianserin in the treatment of depressive illness and anxiety states in general practice. British Journal of Clinical Pharmacology, 5 (Suppl. 1), 81S-85S.
MYERS1984
Myers, E. D. & Calvert, E. J. (1984). Information, compliance and side-effects: a study of patients on antidepressant medication. British Journal of Clinical Pharmacology, 17, 21-25.
NARUSHIMA2000
Narushima, K., Kosier, J. T., & Robinson, R. G. (2000). Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. Journal of Nervous and Mental
Disease, 190, 296-303.
NATALE1979
Natale, M. (1979). The relationship of imipramine plasma levels and verbalized hostility in nondelusional endogenous depressives. Journal of Nervous and Mental Disease, 167, 620-625.
NESHKES1985
Neshkes, R. E., Gerner, R., Jarvik, L. F., Mintz, J., Joseph, J., Linde, S. et al. (1985). Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients. Journal of Clinical
Psychopharmacology, 5, 102-106.
NEWTON1981 (Published Data Only)
Newton, R. (1981). The side effect profile of trazodone in comparison to an active control and placebo. Journal of Clinical Psychopharmacology, 1, 895-935.
NIERENBERG2004 (Published Data Only)
Nierenberg, A. A., Quitkin, F. M., Kremer, C., Keller, M. B., & Thase, M. E. (2004). Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse.
Neuropsychopharmacology., 29, 1012-1018.
NORMAN1983
Norman, T. R., Burrows, G. D., Maguire, K. P., et al. (1983). Maprotiline in affective illness. plasma concentration and clinical response. Journal of Affective Disorders, 5, 147-154.
NORMAN1992
Norman, T. R., Judd, F. K., & Burrows, G. D. (1992). New pharmacological approaches to the management of depression: from theory to clinical practice. Australian & New Zealand Journal of
Psychiatry, 26, 73-81.
NUNES1998
Nunes, E. V., Quitkin, F. M., Donovan, S. J., Deliyannides, D., Ocepek-Welikson, K., Koenig, T. et al. (1998). Imipramine treatment of opiate-dependent patients with depressive disorders. A placebocontrolled
trial. Archives of General Psychiatry, 55, 153-160.
NURNBERG2003
Nurnberg, H. G., Hensley, P. L., Gelenberg, A. J., Fava, M., Lauriello, J., & Paine, S. (2003). Treatment of antidepressant-associated sexual dysfunction with sildenafil: A randomized controlled trial.
JAMA, 289, 56-64.
OPPENHEIM1983
Oppenheim, G. (1983). Estrogen in the treatment of depression: Neuropharmacological mechanisms. Biological Psychiatry, 18, 721-725.
OTTEVANGER1993 (Published Data Only)
Ottevanger, E. A. (1993). Fluvoxamine superior to imipramine in suicidal depressed patients. European Neuropsychopharmacology, 3, 362-363.
OTTEVANGER1994 (Published Data Only)
Ottevanger, E. A. (1994). The efficacy of fluvoxamine in patients with severe depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 18, 731-740.
OVERALL1962 (Published Data Only)
Overall, J. E., Hollister, L. E., POKORNY, A. D., CASEY, J. F., & KATZ, G. (1962). Drug therapy in depressions. Controlled evaluation of imipramine, isocarboxazide,
dextroamphetamineamobarbital, and placebo. Clinical Pharmacology & Therapeutics, 3, 16-22.
OZCANKAYA1997
Ozcankaya, R., Delibas, N., & Ozguner, M. F. (1997). The clomipramine challenge test in major cases of depression and schizophrenia. Turkish Journal of Medical Sciences, 27.
PANDE1993
Pande, A. C. & Sayler, M. E. (1993). Severity of depression and response to fluoxetine. International Clinical Psychopharmacology, 8, 243-245.
84